Reply to Kelly M. de Ligt, Sarah P. Psutka, and Laura S. Mertens’s Letter to the Editor Re: Martino Pedrani, Alberto De Giorgi, Andrea Gallina, et al. When Patients Refuse Radical Cystectomy: Integrating Trimodality Therapy in the Perioperative ICI/ADC Era. Eur Urol Oncol. 2026;9:743–745. http://dx.doi.org/10.1016/j.euo.2026.04.008
Publication date: August 2026 Source: European Urology Oncology, Volume 9, Issue 4 Author(s): Martino Pedrani, Alberto De Giorgi, Andrea Gallina, Ursula Vogl, Thomas Zilli
Reply to Kelly M. de Ligt, Sarah P. Psutka, and Laura S. Mertens’s Letter to the Editor Re: Martino Pedrani, Alberto De Giorgi, Andrea Gallina, et al. When Patients Refuse Radical Cystectomy: Integrating Trimodality Therapy in the Perioperative ICI/ADC Era. Eur Urol Oncol. 2026;9:743–745. http://dx.doi.org/10.1016/j.euo.2026.04.008. // European Urology Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S258893112600194X?dgcid=rss_sd_all
Reply to Kelly M. de Ligt, Sarah P. Psutka, and Laura S. Mertens’s Letter to the Editor Re: Martino Pedrani, Alberto De Giorgi, Andrea Gallina, et al. When Patients Refuse Radical Cystectomy: Integrating Trimodality Therapy in the Perioperative ICI/ADC Era. Eur Urol Oncol. 2026;9:743–745. http://dx.doi.org/10.1016/j.euo.2026.04.008. European Urology Oncology. https://www.sciencedirect.com/science/article/pii/S258893112600194X?dgcid=rss_sd_all
“Reply to Kelly M. de Ligt, Sarah P. Psutka, and Laura S. Mertens’s Letter to the Editor Re: Martino Pedrani, Alberto De Giorgi, Andrea Gallina, et al. When Patients Refuse Radical Cystectomy: Integrating Trimodality Therapy in the Perioperative ICI/ADC Era. Eur Urol Oncol. 2026;9:743–745. http://dx.doi.org/10.1016/j.euo.2026.04.008.” European Urology Oncology.
@article{article97957,
title = {Reply to Kelly M. de Ligt, Sarah P. Psutka, and Laura S. Mertens’s Letter to the Editor Re: Martino Pedrani, Alberto De Giorgi, Andrea Gallina, et al. When Patients Refuse Radical Cystectomy: Integrating Trimodality Therapy in the Perioperative ICI/ADC Era. Eur Urol Oncol. 2026;9:743–745. http://dx.doi.org/10.1016/j.euo.2026.04.008},
journal = {European Urology Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S258893112600194X?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...